Results from Zafirlukast (ACCOLATE) 9188IL/0125 clinical trial.

Study identifier:9188IL/0125

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Official Title

Randomized, Double-blind, Parallel-group Trial to Compare the Safety and Effectiveness of Zafirlukast (ACCOLATE) With That of Pseudoephedrine and Placebo in Subjects With Seasonal Allergic Rhinitis: A Day-in-the-park Trial (9188IL/0125)

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study Start Date: -

Primary Completion Date: -

Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Feb 2022 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

Sort by status

No locations available

Arms	Assigned Interventions

Documents available

CSR synopsis redacted
Download
Trial Results Summaries
Available here